Analytical Data
-
基因名
ITFG1
- Application
-
别名
CDA08; TIP; T Cell Immunomodulatory Protein
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TB96
-
表达区间
Asp55~Asp306
-
分子量
32kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ITFG1, or Intermediate TGF-beta Fujin-Gene 1, is a protein that plays a significant role in various cellular processes, including signal transduction, cell growth, and differentiation. Research into ITFG1 has gained importance due to its potential implications in cancer biology, immune response, and developmental processes. Studies have suggested that dysregulation of ITFG1 may contribute to tumorigenesis and affect the progression of certain diseases, including autoimmune disorders. The characterization of ITFG1, particularly its structure and interactions with other proteins, is essential for understanding its biological functions and pathways. Recent advances in recombinant protein technology have enabled researchers to produce ITFG1 in vitro, facilitating detailed investigations into its functional properties. By understanding the molecular mechanisms underlying ITFG1's activity, scientists aim to identify potential therapeutic targets and develop novel treatment strategies for diseases associated with its dysfunction. This research is crucial for advancing our knowledge of cellular signaling networks and their roles in health and disease.
